PDF

Share on facebook Share on tweeters Share on linkedin Share on googleplus

J Cancer 2025; 16(7):2360-2361. doi:10.7150/jca.113959 This issue Cite

Erratum

Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum

Yong-lin Lu1,*, Ya-bin Ma2,*, Chan Feng1, Dong-lei Zhu1, Jie Liu1, Lv Chen1, Shu-jing Liang1 Corresponding address, Chun-yan Dong1 Corresponding address

1. Breast Cancer Center, Shanghai East Hospital, Tongji University, Shanghai 200120, PR China
2. Department of Pharmacy, Shanghai East Hospital, Tongji University, Shanghai 200120, PR China
*Authors contributed equally to this work.

✉ Corresponding author: Chun-yan Dong: Telephone Number: +86-13370029736; Fax number: 021-61569616; E-mail: cy_dongedu.cn or Shu-jing Liang: Telephone Number: +86-18817821990; Fax number: 021-61569538; E-mail: liangshujing02com

Published 2025-4-12

Citation:
Lu Yl, Ma Yb, Feng C, Zhu Dl, Liu J, Chen L, Liang Sj, Dong Cy. Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum. J Cancer 2025; 16(7):2360-2361. doi:10.7150/jca.113959. https://www.jcancer.org/v16p2360.htm
Other styles

File import instruction

Corrected-article in J Cancer, Volume 10, 2357

 

The original version of this article contained errors in Figure 7B. Specifically, three HE-stained images were incorrectly used; two images (heart and spleen) are from the DOX group, while one image (heart) is from the CYC+DOX group. These errors have now been corrected. All other images in the figure remain unchanged, and the interpretation of the results is unaffected. The authors apologize for any inconvenience this may have caused. The correct images appear below.

 Figure 7 

Histopathological examination of tumors and organs isolated from nude mice after different treatments on day 14. (b). H&E staining of main organs.

J Cancer Image

Author contact

Corresponding address Corresponding author: Chun-yan Dong: Telephone Number: +86-13370029736; Fax number: 021-61569616; E-mail: cy_dongedu.cn or Shu-jing Liang: Telephone Number: +86-18817821990; Fax number: 021-61569538; E-mail: liangshujing02com

Citation styles

APA
Lu, Y.l., Ma, Y.b., Feng, C., Zhu, D.l., Liu, J., Chen, L., Liang, S.j., Dong, C.y. (2025). Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum. Journal of Cancer, 16(7), 2360-2361. https://doi.org/10.7150/jca.113959.

ACS
Lu, Y.l.; Ma, Y.b.; Feng, C.; Zhu, D.l.; Liu, J.; Chen, L.; Liang, S.j.; Dong, C.y. Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum. J. Cancer 2025, 16 (7), 2360-2361. DOI: 10.7150/jca.113959.

NLM
Lu Yl, Ma Yb, Feng C, Zhu Dl, Liu J, Chen L, Liang Sj, Dong Cy. Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum. J Cancer 2025; 16(7):2360-2361. doi:10.7150/jca.113959. https://www.jcancer.org/v16p2360.htm

CSE
Lu Yl, Ma Yb, Feng C, Zhu Dl, Liu J, Chen L, Liang Sj, Dong Cy. 2025. Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum. J Cancer. 16(7):2360-2361.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2025 Ivyspring International Publisher. Terms of use